Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global DNA Sequencing Market, By Product & Services Type
7.1. DNA Sequencing Market, By Product & Services Type, 2020-2030
7.1.1. Consumables
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Instruments
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Services
7.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global DNA Sequencing Market, By Technology Type
8.1. DNA Sequencing Market, By Technology Type, 2020-2030
8.1.1. Sanger Sequencing
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. NGS
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Third Generation Sequencing
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global DNA Sequencing Market, By Workflow Type
9.1. DNA Sequencing Market, By Workflow Type, 2020-2030
9.1.1. Pre-sequencing
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Data Analysis
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global DNA Sequencing Market, By Application Type
10.1. DNA Sequencing Market, By Application Type, 2020-2030
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Reproductive Health
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Clinical Investigation
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Agrigenomics & Forensics
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. HLA Typing/Immune System Monitoring
10.1.5.1. Market Revenue and Forecast (2016-2030)
10.1.6. Metagenomics, Epidemiology & Drug Development
10.1.6.1. Market Revenue and Forecast (2016-2030)
10.1.7. Consumer Genomics
10.1.7.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global DNA Sequencing Market, By End-use Type
11.1. DNA Sequencing Market, By End-use , 2020-2030
11.1.1. Academic Research
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Clinical Research
11.1.2.1. Market Revenue and Forecast (2016-2030)
11.1.3. Hospitals & Clinics
11.1.3.1. Market Revenue and Forecast (2016-2030)
11.1.4. Pharmaceutical & Biotechnology Companies
11.1.4.1. Market Revenue and Forecast (2016-2030)
11.1.5. Other Users
11.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global DNA Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.1.2. Market Revenue and Forecast, By Technology (2016-2030)
12.1.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.1.4. Market Revenue and Forecast, By Application (2016-2030)
12.1.5. Market Revenue and Forecast, By End-use (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.1.6.2. Market Revenue and Forecast, By Technology (2016-2030)
12.1.6.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.1.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.1.7. Market Revenue and Forecast, By End-use (2016-2030)
12.1.8. Rest of North America
12.1.8.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.1.8.2. Market Revenue and Forecast, By Technology (2016-2030)
12.1.8.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.1.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.1.8.5. Market Revenue and Forecast, By End-use (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.2.2. Market Revenue and Forecast, By Technology (2016-2030)
12.2.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.2.4. Market Revenue and Forecast, By Application (2016-2030)
12.2.5. Market Revenue and Forecast, By End-use (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.2.6.2. Market Revenue and Forecast, By Technology (2016-2030)
12.2.6.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.2.7. Market Revenue and Forecast, By Application (2016-2030)
12.2.8. Market Revenue and Forecast, By End-use (2016-2030)
12.2.9. Germany
12.2.9.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.2.9.2. Market Revenue and Forecast, By Technology (2016-2030)
12.2.9.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.2.10. Market Revenue and Forecast, By Application (2016-2030)
12.2.11. Market Revenue and Forecast, By End-use (2016-2030)
12.2.12. France
12.2.12.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.2.12.2. Market Revenue and Forecast, By Technology (2016-2030)
12.2.12.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.2.12.4. Market Revenue and Forecast, By Application (2016-2030)
12.2.13. Market Revenue and Forecast, By End-use (2016-2030)
12.2.14. Rest of Europe
12.2.14.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.2.14.2. Market Revenue and Forecast, By Technology (2016-2030)
12.2.14.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.2.14.4. Market Revenue and Forecast, By Application (2016-2030)
12.2.15. Market Revenue and Forecast, By End-use (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.3.2. Market Revenue and Forecast, By Technology (2016-2030)
12.3.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.3.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.5. Market Revenue and Forecast, By End-use (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.3.6.2. Market Revenue and Forecast, By Technology (2016-2030)
12.3.6.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.3.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.7. Market Revenue and Forecast, By End-use (2016-2030)
12.3.8. China
12.3.8.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.3.8.2. Market Revenue and Forecast, By Technology (2016-2030)
12.3.8.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.3.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.9. Market Revenue and Forecast, By End-use (2016-2030)
12.3.10. Japan
12.3.10.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.3.10.2. Market Revenue and Forecast, By Technology (2016-2030)
12.3.10.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.3.10.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.10.5. Market Revenue and Forecast, By End-use (2016-2030)
12.3.11. Rest of APAC
12.3.11.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.3.11.2. Market Revenue and Forecast, By Technology (2016-2030)
12.3.11.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.3.11.4. Market Revenue and Forecast, By Application (2016-2030)
12.3.11.5. Market Revenue and Forecast, By End-use (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.4.2. Market Revenue and Forecast, By Technology (2016-2030)
12.4.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.4.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.5. Market Revenue and Forecast, By End-use (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.4.6.2. Market Revenue and Forecast, By Technology (2016-2030)
12.4.6.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.4.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.7. Market Revenue and Forecast, By End-use (2016-2030)
12.4.8. North Africa
12.4.8.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.4.8.2. Market Revenue and Forecast, By Technology (2016-2030)
12.4.8.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.4.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.9. Market Revenue and Forecast, By End-use (2016-2030)
12.4.10. South Africa
12.4.10.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.4.10.2. Market Revenue and Forecast, By Technology (2016-2030)
12.4.10.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.4.10.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.10.5. Market Revenue and Forecast, By End-use (2016-2030)
12.4.11. Rest of MEA
12.4.11.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.4.11.2. Market Revenue and Forecast, By Technology (2016-2030)
12.4.11.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.4.11.4. Market Revenue and Forecast, By Application (2016-2030)
12.4.11.5. Market Revenue and Forecast, By End-use (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.5.2. Market Revenue and Forecast, By Technology (2016-2030)
12.5.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.5.4. Market Revenue and Forecast, By Application (2016-2030)
12.5.5. Market Revenue and Forecast, By End-use (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.5.6.2. Market Revenue and Forecast, By Technology (2016-2030)
12.5.6.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.5.6.4. Market Revenue and Forecast, By Application (2016-2030)
12.5.7. Market Revenue and Forecast, By End-use (2016-2030)
12.5.8. Rest of LATAM
12.5.8.1. Market Revenue and Forecast, By Product & Services (2016-2030)
12.5.8.2. Market Revenue and Forecast, By Technology (2016-2030)
12.5.8.3. Market Revenue and Forecast, By Workflow (2016-2030)
12.5.8.4. Market Revenue and Forecast, By Application (2016-2030)
12.5.8.5. Market Revenue and Forecast, By End-use (2016-2030)
Chapter 13. Company Profiles
13.1. Agilent Technologies, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Illumina, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. QIAGEN
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. F. Hoffmann-La Roche Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Oxford Nanopore Technologies Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Macrogen, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Perkin Elmer, Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Pacific Biosciences of California, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. BGI
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Bio-Rad Laboratories, Inc.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. Myriad Genetics
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
13.13. PierianDx
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance
13.13.4. Recent Initiatives
13.14. Intrexon Bioinformatics Germany GmbH
13.14.1. Company Overview
13.14.2. Product Offerings
13.14.3. Financial Performance
13.14.4. Recent Initiatives
13.15. Eurofins Scientific
13.15.1. Company Overview
13.15.2. Product Offerings
13.15.3. Financial Performance
13.15.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms